Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Management of Diarrhea in Patients Taking Bupropion

Initial Assessment and Non-Pharmacological Management

  • The American College of Oncology recommends evaluating the severity of diarrhea by determining the frequency of stools over baseline, stool composition, and presence of nocturnal diarrhea 2
  • The National Comprehensive Cancer Network recommends assessing for concerning symptoms including fever, orthostatic hypotension, abdominal pain/cramping, or weakness that may indicate complications 2
  • Patients taking bupropion should implement dietary modifications, including a BRAT diet (bananas, rice, applesauce, toast) and plain pasta, and eliminate lactose-containing products, alcohol, and high-osmolar dietary supplements 3, 2
  • Ensure adequate hydration with 8-10 large glasses of clear liquids daily (e.g., electrolyte solutions, broth) 1, 2

Pharmacological Management

  • Loperamide is the first-line treatment for managing diarrhea in patients taking bupropion, starting with an initial dose of 4 mg followed by 2 mg every 2-4 hours or after every unformed stool, not exceeding 16 mg daily 1
  • The Annals of Oncology recommends a maximum daily dose of 16 mg of loperamide and to continue until diarrhea-free for at least 12 hours 1, 2
  • For persistent diarrhea, other opioids can be considered, including tincture of opium and low doses of morphine concentrate 1, 3
  • Octreotide can be used as a second-line treatment, starting with a dose of 100-150 μg subcutaneously three times daily, and can be titrated up to 500 mg subcutaneously three times daily or 25-50 mg/hour by continuous IV infusion 1, 2

Special Considerations

  • Monitor for dehydration and electrolyte imbalances, especially in elderly patients or those with comorbidities 2

Monitoring and Follow-up

  • Instruct patients to record the number of stools and report symptoms of life-threatening sequelae (e.g., fever, dizziness upon standing) 2
  • For patients with persistent symptoms, consider referral to a gastroenterologist to rule out other causes of diarrhea 4

Potential Pitfalls and Caveats

  • Recognize that persistent gastrointestinal symptoms might indicate another underlying condition rather than a medication side effect 4
  • Be aware that bile acid sequestrants (e.g., cholestyramine) may interact with bupropion absorption 4

REFERENCES

1

Management of Levetiracetam-Induced Diarrhea [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016